Mixed-type autoimmune hemolytic anemia Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

Regulatory Watchboard

No FDA or trial events recorded yet for Mixed-type autoimmune hemolytic anemia.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Mixed-type autoimmune hemolytic anemia.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Dyural 80-Lm

(METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL)Orphan drugstandard

Advanced Rx Pharmacy of Tennessee, LLC

12.1 Mechanism of Action Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Mixed-type autoimmune hemolytic anemia.
Search all trials →

Search clinical trials for Mixed-type autoimmune hemolytic anemia →

Recent News & Research

No recent news articles indexed yet for Mixed-type autoimmune hemolytic anemia.
Search PubMed for Mixed-type autoimmune hemolytic anemia →

Browse all Mixed-type autoimmune hemolytic anemia news →

Specialist Network

No specialists currently listed for Mixed-type autoimmune hemolytic anemia.

View all Mixed-type autoimmune hemolytic anemia specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰